
NATURE . COM {
}
Title:
Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition | Acta Pharmacologica Sinica
Description:
To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1×106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5−50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Telecommunications
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Estimations show Nature.com's display ad online revenue falls between $42,042 and $115,616 per month.
Keywords {🔍}
cells, luteolin, article, emt, cell, melanoma, google, scholar, cancer, cas, expression, ecadherin, tumor, metastasis, integrin, transition, nature, figure, hypoxia, μmoll, epithelialmesenchymal, mice, lung, analysis, malignant, adhesion, ncadherin, control, wang, hypoxiainduced, potential, liu, zhang, vitro, invasion, vimentin, inhibits, growth, medium, china, incubated, jiangsu, ruan, metastatic, results, model, treatment, human, content, data,
Topics {✒️}
nature portfolio nf-kappab/snail/rkip/pten circuit permissions reprints privacy policy nature pollution research advertising open project e-cadherin-regulating transcription factors culture media shao-ming wang specific pathogen-free conditions integrin/fak signal pathway epithelial-derived cancers21 jun-shan ruan tris-buffered saline-tween-20 social media hypoxia-induced cell adhesion epithelial-mesenchymal transition uvb-induced skin cancer full size image yu-ping liu wrote author correspondence shi-zhong zheng natural science foundation squamous-cell carcinoma potential anti-tumor capacity12 development permissions common human cancers yin lu designed mesenchymal cell state cutaneous malignant melanoma emt-related genes promoted cun-si shen performed acta pharmacol sin epithelial-mesenchymal transitions elicit anti-emt effects jiangsu key laboratory hypoxia-induced model original cobblestone hypoxia-induced switching inhibiting stat3 signaling targeting β3 integrin cell culture model article ruan cell growth factors anti-tumor activity privacy optimas image analyzer
Schema {🗺️}
WebPage:
mainEntity:
headline:Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
description:To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1Ã106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5â50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.
datePublished:2012-09-17T00:00:00Z
dateModified:2012-09-17T00:00:00Z
pageStart:1325
pageEnd:1331
sameAs:https://doi.org/10.1038/aps.2012.93
keywords:
luteolin
epithelial mesenchymal transition
melanoma
hypoxia
E-cadherin
N-cadherin
β3 integrin FAK
Biomedicine
general
Pharmacology/Toxicology
Medical Microbiology
Immunology
Internal Medicine
Vaccine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig4_HTML.jpg
isPartOf:
name:Acta Pharmacologica Sinica
issn:
1745-7254
1671-4083
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jun-shan Ruan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu-ping Liu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Lei Zhang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Ling-geng Yan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Fang-tian Fan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Cun-si Shen
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Ai-yun Wang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Shi-zhong Zheng
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Shao-ming Wang
affiliation:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yin Lu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
address:
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Luteolin reduces the invasive potential of malignant melanoma cells by targeting β3 integrin and the epithelial-mesenchymal transition
description:To investigate whether luteolin, a highly prevalent flavonoid, reverses the effects of epithelial-mesenchymal transition (EMT) in vitro and in vivo and to determine the mechanisms underlying this reversal. Murine malignant melanoma B16F10 cells were exposed to 1% O2 for 24 h. Cellular mobility and adhesion were assessed using Boyden chamber transwell assay and cell adhesion assay, respectively. EMT-related proteins, such as E-cadherin and N-cadherin, were examined using Western blotting. Female C57BL/6 mice (6 to 8 weeks old) were injected with B16F10 cells (1Ã106 cells in 0.2 mL per mouse) via the lateral tail vein. The mice were treated with luteolin (10 or 20 mg/kg, ip) daily for 23 d. On the 23rd day after tumor injection, the mice were sacrificed, and the lungs were collected, and metastatic foci in the lung surfaces were photographed. Tissue sections were analyzed with immunohistochemistry and HE staining. Hypoxia changed the morphology of B16F10 cells in vitro from the cobblestone-like to mesenchymal-like strips, which was accompanied by increased cellular adhesion and invasion. Luteolin (5â50 μmol/L) suppressed the hypoxia-induced changes in the cells in a dose-dependent manner. Hypoxia significantly decreased the expression of E-cadherin while increased the expression of N-cadherin in the cells (indicating the occurrence of EMT-like transformation), which was reversed by luteolin (5 μmol/L). In B16F10 cells, luteolin up-regulated E-cadherin at least partly via inhibiting the β3 integrin/FAK signal pathway. In experimental metastasis model mice, treatment with luteolin (10 or 20 mg/kg) reduced metastatic colonization in the lungs by 50%. Furthermore, the treatment increased the expression of E-cadherin while reduced the expression of vimentin and β3 integrin in the tumor tissues. Luteolin inhibits the hypoxia-induced EMT in malignant melanoma cells both in vitro and in vivo via the regulation of β3 integrin, suggesting that luteolin may be applied as a potential anticancer chemopreventative and chemotherapeutic agent.
datePublished:2012-09-17T00:00:00Z
dateModified:2012-09-17T00:00:00Z
pageStart:1325
pageEnd:1331
sameAs:https://doi.org/10.1038/aps.2012.93
keywords:
luteolin
epithelial mesenchymal transition
melanoma
hypoxia
E-cadherin
N-cadherin
β3 integrin FAK
Biomedicine
general
Pharmacology/Toxicology
Medical Microbiology
Immunology
Internal Medicine
Vaccine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig2_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig3_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Faps.2012.93/MediaObjects/41401_2012_Article_BFaps201293_Fig4_HTML.jpg
isPartOf:
name:Acta Pharmacologica Sinica
issn:
1745-7254
1671-4083
volumeNumber:33
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Jun-shan Ruan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yu-ping Liu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Lei Zhang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Ling-geng Yan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Fang-tian Fan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Cun-si Shen
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Ai-yun Wang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Shi-zhong Zheng
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
type:Person
name:Shao-ming Wang
affiliation:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
type:Person
name:Yin Lu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
address:
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Acta Pharmacologica Sinica
issn:
1745-7254
1671-4083
volumeNumber:33
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
address:
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Jun-shan Ruan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
name:Yu-ping Liu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Lei Zhang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Ling-geng Yan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Fang-tian Fan
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Cun-si Shen
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Ai-yun Wang
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Shi-zhong Zheng
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Shao-ming Wang
affiliation:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University
address:
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
type:PostalAddress
type:Organization
name:Yin Lu
affiliation:
name:College of Pharmacy, Nanjing University of Chinese Medicine
address:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
type:PostalAddress
type:Organization
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica
address:
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Fujian Provincial Hospital, Clinical College of Fujian Medical University, Fuzhou, China
name:Department of Clinical Pharmacy, College of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China
name:Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, Nanjing, China
External Links {🔗}(99)
- What's the financial intake of https://mc.manuscriptcentral.com/aphs?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Skin%20cancer%3A%20Novel%20resistance%20mechanism%20revealed&journal=Nat%20Rev%20Clin%20Oncol&volume=9&publication_year=2012&author=Hutchinson%2CL
- What's the income generated by https://doi.org/10.1111%2Fj.1525-1470.2009.01078.x each month?
- Revenue of http://scholar.google.com/scholar_lookup?&title=Melanoma%20and%20melanocytic%20tumors%20of%20uncertain%20malignant%20potential%20in%20children%2C%20adolescents%20and%20young%20adults%20%E2%80%94%20the%20Stanford%20experience%201995%E2%80%932008&journal=Pediatr%20Dermatol&doi=10.1111%2Fj.1525-1470.2009.01078.x&volume=27&pages=244-54&publication_year=2010&author=Berk%2CDR&author=LaBuz%2CE&author=Dadras%2CSS&author=Johnson%2CDL&author=Swetter%2CSM
- What's the revenue for https://doi.org/10.1016%2Fj.ophtha.2007.01.032?
- http://scholar.google.com/scholar_lookup?&title=Incidence%20of%20uveal%20melanoma%20in%20Europe&journal=Ophthalmology&doi=10.1016%2Fj.ophtha.2007.01.032&volume=114&pages=2309-15&publication_year=2007&author=Virgili%2CG&author=Gatta%2CG&author=Ciccolallo%2CL&author=Capocaccia%2CR&author=Biggeri%2CA&author=Crocetti%2CE's financial summary
- What's the financial outcome of https://doi.org/10.1016%2Fj.jaad.2011.04.038?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Melanoma%20in%20adolescents%20and%20young%20adults%20%28ages%2015%E2%80%9339%20years%29%3A%20United%20States%2C%201999%E2%80%932006&journal=J%20Am%20Acad%20Dermatol&doi=10.1016%2Fj.jaad.2011.04.038&volume=65&pages=S38-49&publication_year=2011&author=Weir%2CHK&author=Marrett%2CLD&author=Cokkinides%2CV&author=Barnholtz-Sloan%2CJ&author=Patel%2CP&author=Tai%2CE make?
- How much does https://doi.org/10.1016%2Fj.cell.2008.03.027 bring in each month?
- How much cash flow does http://scholar.google.com/scholar_lookup?&title=The%20epithelial-mesenchymal%20transition%20generates%20cells%20with%20properties%20of%20stem%20cells&journal=Cell&doi=10.1016%2Fj.cell.2008.03.027&volume=133&pages=704-15&publication_year=2008&author=Mani%2CSA&author=Guo%2CW&author=Liao%2CMJ&author=Eaton%2CEN&author=Ayyanan%2CA&author=Zhou%2CAY have monthly?
- See how much https://link.springer.com/doi/10.1186/bcr2938 makes per month
- How profitable is http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transition%2C%20cancer%20stem%20cells%20and%20treatment%20resistance&journal=Breast%20Cancer%20Res&doi=10.1186%2Fbcr2938&volume=14&publication_year=2012&author=Dave%2CB&author=Mittal%2CV&author=Tan%2CNM&author=Chang%2CJC?
- Check the income stats for https://link.springer.com/doi/10.1007/s12307-011-0087-2
- How much profit does http://scholar.google.com/scholar_lookup?&title=Adipocytes%20promote%20B16BL6%20melanoma%20cell%20invasion%20and%20the%20epithelial-to-mesenchymal%20transition&journal=Cancer%20Microenviron&doi=10.1007%2Fs12307-011-0087-2&volume=5&pages=73-82&publication_year=2012&author=Kushiro%2CK&author=Chu%2CRA&author=Verma%2CA&author=Nunez%2CNP generate?
- What's the monthly money flow for https://doi.org/10.1258%2Febm.2010.010106?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Contact%20by%20melanoma%20cells%20causes%20malignant%20transformation%20of%20human%20epithelial-like%20stem%20cells%20via%20alpha%20V%20integrin%20activation%20of%20transforming%20growth%20factor%20beta1%20signaling&journal=Exp%20Biol%20Med%20%28Maywood%29&doi=10.1258%2Febm.2010.010106&volume=236&pages=352-65&publication_year=2011&author=Sun%2CH&author=Hu%2CK&author=Wu%2CM&author=Xiong%2CJ&author=Yuan%2CL&author=Tang%2CY
- Profit of https://doi.org/10.1371%2Fjournal.pbio.1001162
- How much money does http://scholar.google.com/scholar_lookup?&title=Mesenchymal%20transition%20and%20dissemination%20of%20cancer%20cells%20is%20driven%20by%20myeloid-derived%20suppressor%20cells%20infiltrating%20the%20primary%20tumor&journal=PLoS%20Biol&doi=10.1371%2Fjournal.pbio.1001162&volume=9&publication_year=2011&author=Toh%2CB&author=Wang%2CX&author=Keeble%2CJ&author=Sim%2CWJ&author=Khoo%2CK&author=Wong%2CWC make?
- How much cash flow does https://doi.org/10.1177%2F1947601910373795 have monthly?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=The%20role%20of%20B-RAF%20mutations%20in%20melanoma%20and%20the%20induction%20of%20EMT%20via%20dysregulation%20of%20the%20NF-kappaB%2FSnail%2FRKIP%2FPTEN%20circuit&journal=Genes%20Cancer&doi=10.1177%2F1947601910373795&volume=1&pages=409-20&publication_year=2010&author=Lin%2CK&author=Baritaki%2CS&author=Militello%2CL&author=Malaponte%2CG&author=Bevelacqua%2CY&author=Bonavida%2CB
- What's the income generated by https://doi.org/10.1158%2F0008-5472.CAN-06-3481 each month?
- How much does http://scholar.google.com/scholar_lookup?&title=A%20high-throughput%20study%20in%20melanoma%20identifies%20epithelial-mesenchymal%20transition%20as%20a%20major%20determinant%20of%20metastasis&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-06-3481&volume=67&pages=3450-60&publication_year=2007&author=Alonso%2CSR&author=Tracey%2CL&author=Ortiz%2CP&author=Perez-Gomez%2CB&author=Palacios%2CJ&author=Pollan%2CM make?
- What's the total monthly financial gain of https://doi.org/10.2174%2F156800908786241050?
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Luteolin%2C%20a%20flavonoid%20with%20potential%20for%20cancer%20prevention%20and%20therapy&journal=Curr%20Cancer%20Drug%20Targets&doi=10.2174%2F156800908786241050&volume=8&pages=634-46&publication_year=2008&author=Lin%2CY&author=Shi%2CR&author=Wang%2CX&author=Shen%2CHM is on a monthly basis
- What's the revenue for https://doi.org/10.1158%2F1535-7163.MCT-09-0191?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Luteolin%20inhibits%20invasion%20of%20prostate%20cancer%20PC3%20cells%20through%20E-cadherin&journal=Mol%20Cancer%20Ther&doi=10.1158%2F1535-7163.MCT-09-0191&volume=8&pages=1684-91&publication_year=2009&author=Zhou%2CQ&author=Yan%2CB&author=Hu%2CX&author=Li%2CXB&author=Zhang%2CJ&author=Fang%2CJ?
- How much does https://doi.org/10.1074%2Fjbc.M109.023960 bring in each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Reversibility%20of%20epithelial-mesenchymal%20transition%20%28EMT%29%20induced%20in%20breast%20cancer%20cells%20by%20activation%20of%20urokinase%20receptor-dependent%20cell%20signaling&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M109.023960&volume=284&pages=22825-33&publication_year=2009&author=Jo%2CM&author=Lester%2CRD&author=Montel%2CV&author=Eastman%2CB&author=Takimoto%2CS&author=Gonias%2CSL earn?
- How much revenue does https://doi.org/10.1016%2Fj.bbrc.2009.06.042 produce monthly?
- What's the income generated by http://scholar.google.com/scholar_lookup?&title=Ligustrazine%20inhibits%20B16F10%20melanoma%20metastasis%20and%20suppresses%20angiogenesis%20induced%20by%20vascular%20endothelial%20growth%20factor&journal=Biochem%20Biophys%20Res%20Commun&doi=10.1016%2Fj.bbrc.2009.06.042&volume=386&pages=374-9&publication_year=2009&author=Chen%2CL&author=Lu%2CY&author=Wu%2CJM&author=Xu%2CB&author=Zhang%2CLJ&author=Gao%2CM each month?
- Income figures for https://link.springer.com/doi/10.1007/s00280-010-1378-x
- How much does http://scholar.google.com/scholar_lookup?&title=Beta-elemene%20inhibits%20melanoma%20growth%20and%20metastasis%20via%20suppressing%20vascular%20endothelial%20growth%20factor-mediated%20angiogenesis&journal=Cancer%20Chemother%20Pharmacol&doi=10.1007%2Fs00280-010-1378-x&volume=67&pages=799-808&publication_year=2011&author=Chen%2CW&author=Lu%2CY&author=Wu%2CJ&author=Gao%2CM&author=Wang%2CA&author=Xu%2CB pull in?
- How much income does https://doi.org/10.1016%2Fj.ejphar.2010.06.045 have?
- What's http://scholar.google.com/scholar_lookup?&title=Danshensu%20has%20anti-tumor%20activity%20in%20B16F10%20melanoma%20by%20inhibiting%20angiogenesis%20and%20tumor%20cell%20invasion&journal=Eur%20J%20Pharmacol&doi=10.1016%2Fj.ejphar.2010.06.045&volume=643&pages=195-201&publication_year=2010&author=Zhang%2CLJ&author=Chen%2CL&author=Lu%2CY&author=Wu%2CJM&author=Xu%2CB&author=Sun%2CZG's gross income?
- How much does https://doi.org/10.4161%2Fcbt.11.8.15274 bring in each month?
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=EMT%3A%20a%20new%20vision%20of%20hypoxia%20promoting%20cancer%20progression&journal=Cancer%20Biol%20Ther&doi=10.4161%2Fcbt.11.8.15274&volume=11&pages=714-23&publication_year=2011&author=Jiang%2CJ&author=Tang%2CYL&author=Liang%2CXH
- Check the income stats for https://link.springer.com/doi/10.1186/2045-3701-1-29
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transition%20in%20tumor%20microenvironment&journal=Cell%20Biosci&doi=10.1186%2F2045-3701-1-29&volume=1&publication_year=2011&author=Jing%2CY&author=Han%2CZ&author=Zhang%2CS&author=Liu%2CY&author=Wei%2CL?
- https://doi.org/10.1016%2Fj.febslet.2009.10.065's revenue stream
- Income figures for http://scholar.google.com/scholar_lookup?&title=Glycosynaptic%20microdomains%20controlling%20tumor%20cell%20phenotype%20through%20alteration%20of%20cell%20growth%2C%20adhesion%2C%20and%20motility&journal=FEBS%20Lett&doi=10.1016%2Fj.febslet.2009.10.065&volume=584&pages=1901-6&publication_year=2010&author=Hakomori%2CSI
- https://doi.org/10.1016%2Fj.cell.2011.11.025's total income per month
- How much profit does http://scholar.google.com/scholar_lookup?&title=EMT%20and%20dissemination%20precede%20pancreatic%20tumor%20formation&journal=Cell&doi=10.1016%2Fj.cell.2011.11.025&volume=148&pages=349-61&publication_year=2012&author=Rhim%2CAD&author=Mirek%2CET&author=Aiello%2CNM&author=Maitra%2CA&author=Bailey%2CJM&author=McAllister%2CF generate?
- Financial intake of https://doi.org/10.1016%2Fj.bmc.2010.01.046
- What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Melanogenesis%20inhibitors%20from%20the%20desert%20plant%20Anastatica%20hierochuntica%20in%20B16%20melanoma%20cells&journal=Bioorg%20Med%20Chem&doi=10.1016%2Fj.bmc.2010.01.046&volume=18&pages=2337-45&publication_year=2010&author=Nakashima%2CS&author=Matsuda%2CH&author=Oda%2CY&author=Nakamura%2CS&author=Xu%2CF&author=Yoshikawa%2CM?
- What are the total earnings of https://doi.org/10.1158%2F0008-5472.CAN-05-4062?
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=Luteolin%20promotes%20degradation%20in%20signal%20transducer%20and%20activator%20of%20transcription%203%20in%20human%20hepatoma%20cells%3A%20an%20implication%20for%20the%20antitumor%20potential%20of%20flavonoids&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-05-4062&volume=66&pages=4826-34&publication_year=2006&author=Selvendiran%2CK&author=Koga%2CH&author=Ueno%2CT&author=Yoshida%2CT&author=Maeyama%2CM&author=Torimura%2CT
- How much income does https://doi.org/10.1158%2F0008-5472.CAN-09-4093 have?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Luteolin%20inhibits%20protein%20kinase%20C%28epsilon%29%20and%20c-Src%20activities%20and%20UVB-induced%20skin%20cancer&journal=Cancer%20Res&doi=10.1158%2F0008-5472.CAN-09-4093&volume=70&pages=2415-23&publication_year=2010&author=Byun%2CS&author=Lee%2CKW&author=Jung%2CSK&author=Lee%2CEJ&author=Hwang%2CMK&author=Lim%2CSH?
- Profit of https://doi.org/10.1016%2Fj.freeradbiomed.2011.03.008
- How much does http://scholar.google.com/scholar_lookup?&title=Luteolin%20inhibits%20Nrf2%20leading%20to%20negative%20regulation%20of%20the%20Nrf2%2FARE%20pathway%20and%20sensitization%20of%20human%20lung%20carcinoma%20A549%20cells%20to%20therapeutic%20drugs&journal=Free%20Radic%20Biol%20Med&doi=10.1016%2Fj.freeradbiomed.2011.03.008&volume=50&pages=1599-609&publication_year=2011&author=Tang%2CX&author=Wang%2CH&author=Fan%2CL&author=Wu%2CX&author=Xin%2CA&author=Ren%2CH gross monthly?
- What is the earnings of https://doi.org/10.1111%2Fj.1349-7006.2011.02035.x?
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=Effects%20of%20dietary%20flavonoids%2C%20luteolin%2C%20and%20quercetin%20on%20the%20reversal%20of%20epithelial-mesenchymal%20transition%20in%20A431%20epidermal%20cancer%20cells&journal=Cancer%20Sci&doi=10.1111%2Fj.1349-7006.2011.02035.x&volume=102&pages=1829-39&publication_year=2011&author=Lin%2CYS&author=Tsai%2CPH&author=Kandaswami%2CCC&author=Cheng%2CCH&author=Ke%2CFC&author=Lee%2CPP?
- What's the financial intake of https://doi.org/10.1681%2FASN.2006111194?
- What's http://scholar.google.com/scholar_lookup?&title=Biliverdin%20reductase%20mediates%20hypoxia-induced%20EMT%20via%20PI3-kinase%20and%20Akt&journal=J%20Am%20Soc%20Nephrol&doi=10.1681%2FASN.2006111194&volume=19&pages=380-7&publication_year=2008&author=Zeng%2CR&author=Yao%2CY&author=Han%2CM&author=Zhao%2CX&author=Liu%2CXC&author=Wei%2CJ's gross income?
- How much money does https://doi.org/10.1016%2Fj.biocel.2010.06.023 make?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Differential%20regulation%20of%20Snail%20by%20hypoxia%20and%20hyperglycemia%20in%20human%20proximal%20tubule%20cells&journal=Int%20J%20Biochem%20Cell%20Biol&doi=10.1016%2Fj.biocel.2010.06.023&volume=42&pages=1689-97&publication_year=2010&author=Sumual%2CS&author=Saad%2CS&author=Tang%2CO&author=Yong%2CR&author=McGinn%2CS&author=Chen%2CXM?
- How much does https://doi.org/10.1016%2Fj.canlet.2011.09.039 pull in monthly?
- http://scholar.google.com/scholar_lookup?&title=Characterization%20of%20a%20cell%20culture%20model%20for%20clinically%20aggressive%20hepatocellular%20carcinoma%20induced%20by%20chronic%20hypoxia&journal=Cancer%20Lett&doi=10.1016%2Fj.canlet.2011.09.039&volume=315&pages=178-88&publication_year=2012&author=van%2CMH&author=Verslype%2CC&author=Windmolders%2CP&author=van%2CER&author=Nevens%2CF&author=van%2CPJ's total income per month
- Monthly income for https://doi.org/10.1016%2Fj.radonc.2011.05.044
- What's the total monthly financial gain of http://scholar.google.com/scholar_lookup?&title=E-cadherin%20loss%20associated%20with%20EMT%20promotes%20radioresistance%20in%20human%20tumor%20cells&journal=Radiother%20Oncol&doi=10.1016%2Fj.radonc.2011.05.044&volume=99&pages=392-7&publication_year=2011&author=Theys%2CJ&author=Jutten%2CB&author=Habets%2CR&author=Paesmans%2CK&author=Groot%2CAJ&author=Lambin%2CP?
- How much revenue does https://doi.org/10.1016%2Fj.cell.2009.11.007 bring in?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Epithelial-mesenchymal%20transitions%20in%20development%20and%20disease&journal=Cell&doi=10.1016%2Fj.cell.2009.11.007&volume=139&pages=871-90&publication_year=2009&author=Thiery%2CJP&author=Acloque%2CH&author=Huang%2CRY&author=Nieto%2CMA
- Learn how profitable https://doi.org/10.1016%2Fj.cell.2011.05.040 is on a monthly basis
- What's the income of http://scholar.google.com/scholar_lookup?&title=Biomechanical%20remodeling%20of%20the%20microenvironment%20by%20stromal%20caveolin-1%20favors%20tumor%20invasion%20and%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2011.05.040&volume=146&pages=148-63&publication_year=2011&author=Goetz%2CJG&author=Minguet%2CS&author=Navarro-Lerida%2CI&author=Lazcano%2CJJ&author=Samaniego%2CR&author=Calvo%2CE?
- How much does https://doi.org/10.1016%2F0092-8674%2894%2990149-X net monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Expression%20of%20the%20integrin%20alpha%204%20beta%201%20on%20melanoma%20cells%20can%20inhibit%20the%20invasive%20stage%20of%20metastasis%20formation&journal=Cell&doi=10.1016%2F0092-8674%2894%2990149-X&volume=77&pages=335-47&publication_year=1994&author=Qian%2CF&author=Vaux%2CDL&author=Weissman%2CIL generate monthly?
- How much revenue does https://doi.org/10.1016%2Fj.cell.2009.12.016 produce monthly?
- Get to know http://scholar.google.com/scholar_lookup?&title=Integrins%20and%20mutant%20p53%20on%20the%20road%20to%20metastasis&journal=Cell&doi=10.1016%2Fj.cell.2009.12.016&volume=139&pages=1220-2&publication_year=2009&author=Selivanova%2CG&author=Ivaska%2CJ's earnings
- https://citation-needed.springer.com/v2/references/10.1038/aps.2012.93?format=refman&flavour=references's revenue stream
- What is the monthly revenue of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jun-shan%20Ruan?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jun-shan%20Ruan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate monthly?
- Income figures for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yu-ping%20Liu
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yu-ping%20Liu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in monthly?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lei%20Zhang earn?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lei%20Zhang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ling-geng%20Yan?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ling-geng%20Yan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Fang-tian%20Fan pull in monthly?
- What's the financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Fang-tian%20Fan%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Explore the financials of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Cun-si%20Shen
- What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Cun-si%20Shen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Ai-yun%20Wang?
- What's the income generated by https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Ai-yun%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en each month?
- What are the total earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shi-zhong%20Zheng?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shi-zhong%20Zheng%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Shao-ming%20Wang produce monthly?
- How much money does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Shao-ming%20Wang%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yin%20Lu making per month?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yin%20Lu%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the financial outcome of https://s100.copyright.com/AppDispatchServlet?title=Luteolin%20reduces%20the%20invasive%20potential%20of%20malignant%20melanoma%20cells%20by%20targeting%20%CE%B23%20integrin%20and%20the%20epithelial-mesenchymal%20transition&author=Jun-shan%20Ruan%20et%20al&contentID=10.1038%2Faps.2012.93©right=CPS%20and%20SIMM&publication=1671-4083&publicationDate=2012-09-17&publisherName=SpringerNature&orderBeanReset=true?
- How much revenue does https://citation-needed.springer.com/v2/references/10.1038/aps.2012.93?format=refman&flavour=citation bring in?
- What's https://doi.org/10.1007/s13204-022-02546-y's gross income?
- How much does https://doi.org/10.1186/s12986-019-0365-4 rake in every month?
- Find out how much https://doi.org/10.1007/s11356-018-3477-x earns monthly
- What is the earnings of https://doi.org/10.1038/s41598-017-03351-2?
- What's https://www.protocols.io/'s gross income?
- How profitable is https://www.natureindex.com/?
- How much revenue does http://www.naturechina.com produce monthly?
- How much does https://www.natureasia.com/ja-jp pull in monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref